CHRISTINE COUPERUS-MASHEWSKE: Open Payments
NPI 1700260221 · CANTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 10 payments from 7 companies in 2025. Trend: 2023 $532 · 2024 $1,116 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $74 |
| ABBVIE INC. | 2 | $32 |
| Lundbeck LLC | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: ARISTADA, REXULTI, VRAYLAR, FANAPT, CAPLYTA, Auvelity.
Industry payments across NY — which companies pay providers there.
